Agah Ramtin's Form 4 filing
RenovoRx, Inc. (RNXT) · filed Jun 9, 2022
- Accession no.
- 0001493152-22-016226
- Filed
- Jun 9, 2022
- Trade date
- Mar 16-Jun 7, 2022
- Filing delay
- 85 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $10.0K. It was filed 85 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Agah RamtinCIK 0001862617 | Director, Officer (Chief Medical Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2022 | Common Stock | GGiftDisposed | −975,000 | $0.00 | $0 | 1,295 | Direct | |
| Mar 16, 2022 | Common Stock | GGiftAcquired | +975,000 | $0.00 | $0 | 975,000 | Indirect | |
| Jun 7, 2022 | Common Stock | PPurchaseAcquired | +5,182 | $1.93 | +$10,001.26 | 6,477 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.